ChinaHealthcare and life sciences2025 – ongoingFosun Pharma
PharmAID internal medical writing and decision support
Fosun Pharma released PharmAID internally and claimed 50% higher medical content accuracy than general models
Problem
Drug research required access to specialist clinical information and support for medical writing.
Approach
Fosun Pharma developed PharmAID internally and integrated large language models, including DeepSeek R1. The platform connected specialist clinical and drug-pipeline databases and provided translation and medical writing or revision functions.
Results
Takeaway
The claimed accuracy improvement concerned medical content generation. Fosun Pharma did not disclose the evaluation method or identify the general models used for comparison.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- IT and R&DInternal work and knowledge management
- Innovation type
- Process innovation
- AI technology
- Generative AI
- Adoption
- Built in-house
- Evidence
- Company's own claim
Sources
Source summaries
Fosun Pharma reported the internal release of PharmAID and its connections to specialist clinical and pipeline databases. It claimed medical content-generation accuracy improved 50% over general models, without publishing its evaluation method.
Full details are in the original sources.